Ligand Pharmaceuticals Incorporated Insider Transactions
Purchase
Sell
Ligand Pharmaceuticals Incorporated Insider Trades History
| Insider Name | Buy/Sell | Shares Bought/Sold @ Price |
Total Transaction | Shares Held After Transaction |
Transaction Date | Filing Date | Details |
|---|---|---|---|---|---|---|---|
|
Reardon Andrew
CLO & Secretary |
Sell | 1,000 @ $104.00 | $104.00 K | 32,903 | 05/15/2025 | 06/02/2025 | |
|
Espinoza Octavio
CFO |
Buy | 500 @ $104.40 | $52.20 K | 27,932 | 05/09/2025 | 05/13/2025 | |
|
Davis Todd C
CEO |
Buy | 5,523 @ $105.67 | $583.63 K | 161,234 | 05/09/2025 | 05/13/2025 | |
|
Espinoza Octavio
CFO |
Buy | 1,000 @ $103.89 | $103.89 K | 27,432 | 05/09/2025 | 05/13/2025 | |
|
Davis Todd C
CEO |
Buy | 1,680 @ $104.57 | $175.68 K | 153,404 | 05/09/2025 | 05/13/2025 | |
|
Davis Todd C
CEO |
Buy | 2,307 @ $104.53 | $241.15 K | 155,711 | 05/09/2025 | 05/13/2025 | |
|
Espinoza Octavio
CFO |
Sell | 5,000 @ $115.03 | $575.15 K | 18,879 | 03/04/2025 | 03/06/2025 | |
|
Espinoza Octavio
CFO |
Sell | 2,104 @ $116.37 | $244.85 K | 20,647 | 12/23/2024 | 12/26/2024 | |
|
LAMATTINA JOHN L
Director |
Sell | 2,406 @ $123.65 | $297.50 K | 29,515 | 11/27/2024 | 12/02/2024 | |
|
Korenberg Matthew E
President & COO |
Sell | 2,481 @ $100.05 | $248.23 K | 58,068 | 09/23/2024 | 09/24/2024 | |
|
Reardon Andrew
CLO & Secretary |
Sell | 2,000 @ $99.60 | $199.20 K | 22,534 | 09/23/2024 | 09/25/2024 | |
|
Korenberg Matthew E
President & COO |
Sell | 7,090 @ $101.61 | $720.38 K | 50,978 | 09/23/2024 | 09/24/2024 | |
|
Korenberg Matthew E
President & COO |
Sell | 201 @ $102.05 | $20.51 K | 50,777 | 09/23/2024 | 09/24/2024 | |
|
Espinoza Octavio
CFO |
Sell | 200 @ $103.98 | $20.80 K | 25,685 | 09/20/2024 | 09/24/2024 | |
|
Korenberg Matthew E
President & COO |
Sell | 6,275 @ $104.10 | $653.24 K | 50,777 | 09/20/2024 | 09/24/2024 | |
|
Espinoza Octavio
CFO |
Sell | 275 @ $103.86 | $28.56 K | 25,410 | 09/20/2024 | 09/24/2024 | |
|
Espinoza Octavio
CFO |
Sell | 800 @ $103.95 | $83.16 K | 24,610 | 09/20/2024 | 09/24/2024 | |
|
Reardon Andrew
CLO & Secretary |
Sell | 1,500 @ $106.39 | $159.59 K | 22,534 | 08/28/2024 | 08/30/2024 | |
|
Korenberg Matthew E
President & COO |
Sell | 6,177 @ $105.02 | $648.68 K | 54,722 | 08/26/2024 | 08/26/2024 | |
|
Korenberg Matthew E
President & COO |
Sell | 5,212 @ $106.32 | $554.15 K | 49,510 | 08/26/2024 | 08/26/2024 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Ligand Pharmaceuticals Incorporated FAQ's
The list of insiders at Ligand Pharmaceuticals Incorporated includes Davis Todd C, Korenberg Matthew E, Reardon Andrew, Espinoza Octavio, LAMATTINA JOHN L.
Insiders have sold a total of 68.44 K Ligand Pharmaceuticals Incorporated shares in the last 12 months for a total of 7.14 M sold.
The following insiders have sold Ligand Pharmaceuticals Incorporated shares in the last 12 months: Korenberg Matthew E ($5.43 M), Reardon Andrew ($462.79 K), Espinoza Octavio ($952.52 K), LAMATTINA JOHN L ($297.50 K),
Insiders have purchased a total of 13.51 K Ligand Pharmaceuticals Incorporated shares in the last 12 months for a total of 1.40 M.
The following insiders have purchased Ligand Pharmaceuticals Incorporated shares in the last 12 months: Davis Todd C ($1.24 M), Espinoza Octavio ($156.09 K),